Factor V Leiden Mutation, DNA
Also called FVL, thrombophilia panel
A one-time genetic test for the most common inherited clotting disorder — a mutation that makes blood more prone to forming clots.
- Lab price$175.00
- RetestNever — fixed for life
What your result means
Genuinely important for two groups in this audience: anyone with elevated hematocrit from TRT or AAS (clot risk compounds), and women considering estrogen-containing contraceptives or HRT, where the combination substantially multiplies clot risk.
- Standard
- Samethe estrogen interaction makes it especially relevant in women
- Optimal
- Negative.
- Standard
- Negative / heterozygous / homozygous
- Optimal
- Negative.
Genetic resultFixed for life. It changes what you should watch, not what you can change.
Order it yourself
One test, drawn at a Quest lab near you. The price is the lab’s, from Marek’s own menu.
Code CAMERON takes 10% off. Marek’s checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.
What moves Factor V Leiden Mutation, DNA
Inherited. Present in roughly 3–8% of people of European descent.
If it’s high: Heterozygous carriers have a modestly increased clot risk; homozygous substantially higher. Combined with estrogen contraceptives, elevated hematocrit, immobility, surgery or long flights, the risk compounds meaningfully.
If it’s low: Normal.

The free Before‑You‑Stack Lab Kit
The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.
After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.
Everything else about Factor V Leiden Mutation, DNA
What your Factor V Leiden Mutation, DNA result means
Each possible result, and what to do next
What did your Factor V Leiden result show?
- Negative
- This particular inherited clotting risk is ruled out. Other thrombophilias exist, so a personal or family history of clots still deserves investigation.
- Heterozygous (one copy)
- Roughly a fourfold increase in venous thrombosis risk over baseline — which sounds alarming and remains a low absolute risk for most people. It matters most in combination with other factors: estrogen-containing contraception, pregnancy, immobility, surgery and long flights.
- Homozygous (two copies)
- Substantially higher risk than heterozygous. This changes decisions around contraception, hormone therapy, surgery and travel, and it belongs in a conversation with a clinician rather than a self-managed plan.
What to do next. This is a result that changes specific decisions rather than daily habits. Tell any prescriber before starting estrogen-containing contraception or HRT, and before any surgery. Move on long flights. Nothing in the Vault substitutes for hematology input here, and the nattokinase and lumbrokinase entries carry bleeding-risk cautions that matter more in this group, not less.
What can skew the result
3 things can change the reading or the real level
Some change your real level; others only change the reading. Each one says which, and what to do about it.
- Nothing physiological affects the genotypeAssay
Fixed for life — but note the distinction from the FUNCTIONAL test: activated protein C resistance testing IS affected by anticoagulants, pregnancy and the pill. The genetic test is not.
Do this: If you are anticoagulated or pregnant, ask for the genetic test rather than the functional assay.
The number is wrong — repeat it- Heterozygous and homozygous are very different situationsAssay
One copy raises clot risk modestly; two copies raise it far more. A report saying only 'positive' conflates them.
Do this: Get the zygosity, not just positive or negative.
The number is wrong — repeat it- It changes contraception, surgery and travel decisionsSample prep
Combined hormonal contraception carries markedly higher risk with Factor V Leiden, and it affects advice around surgery, pregnancy and long-haul travel.
Do this: A positive result is a conversation with a doctor — and it matters for your siblings and children too.
The draw itself skewed it — repeat it
Symptoms it helps explain
1 symptom, and which to test first
Test this first if you have
- Blood clot, DVT, or clotting runs in my family
Plan of attack
What to do, in this order
- Confirm the number is real
Nothing physiological affects the genotype. Fixed for life — but note the distinction from the FUNCTIONAL test: activated protein C resistance testing IS affected by anticoagulants, pregnancy and the pill. The genetic test is not. If you are anticoagulated or pregnant, ask for the genetic test rather than the functional assay.
- Read it with its partner
A one-time test that meaningfully changes risk decisions for life. Draw it alongside: Complete Blood Count (CBC) with Differential, Fibrinogen Activity, D-Dimer.
- Work out which direction is yours
If it's high — Heterozygous carriers have a modestly increased clot risk; homozygous substantially higher. Combined with estrogen contraceptives, elevated hematocrit, immobility, surgery or long flights, the risk compounds meaningfully.
If it's low — Normal. - Fix it in order: food, then cause, then everything else
Nutrition. No dietary treatment. Adequate hydration supports normal viscosity.
Lifestyle. Move on long flights and drives, stay hydrated, avoid prolonged immobility, don't smoke. Know the warning signs of DVT (unilateral leg swelling, pain, warmth) and PE (sudden shortness of breath, chest pain). - Retest
Never — fixed for life. Change one thing at a time, or the retest can't tell you which thing worked.
Where the optimal range comes from
Not a range — a result category
Not a range — a result category. Positive or negative, a titre, a genotype. The useful content is what each answer means and what to do next.
- Measured in
- Inherited. Present in roughly 3–8% of people of European descent; rare in other ancestries.
- Anchored to
- A fixed genotype: negative, heterozygous or homozygous. Risk is categorical and lifelong.
- Source
- Interpretation is categorical; see the result-category block on this page.
A genotype cannot have an optimal range, and treating it as a number to improve is the error to avoid. What the result changes is decisions: estrogen-containing contraception and HRT, how aggressively to manage a high hematocrit, and thromboprophylaxis around surgery and long immobility. It is a one-time test and it never needs repeating.
What Factor V Leiden Mutation, DNA measures
And why people check it
What it tells you
A one-time genetic test for the most common inherited clotting disorder — a mutation that makes blood more prone to forming clots.
Why people check it
Genuinely important for two groups in this audience: anyone with elevated hematocrit from TRT or AAS (clot risk compounds), and women considering estrogen-containing contraceptives or HRT, where the combination substantially multiplies clot risk.
What Factor V Leiden Mutation, DNA means next to other markers
1 pattern worth knowing
- Factor V Leiden — zygosity changes everything
Factor V Leiden positive · heterozygous vs homozygous
One copy raises clot risk modestly; two copies raise it far more. A report saying only 'positive' conflates two quite different situations. It also changes contraception advice substantially, and matters around surgery, pregnancy and long-haul travel.
Get the zygosity. Combined hormonal contraception carries markedly higher risk with this variant — that is a prescriber conversation, and it matters for siblings and children too.
Panels that carry Factor V Leiden Mutation, DNA
1 panel, prices with code CAMERON
Read it alongside
Related markers, goals and what moves it in the library
The deep read, with sources
What the Factor V Leiden Mutation, DNA test actually measures, and the references
What Factor V Leiden Mutation, DNA actually measures — the analyte, and the assay
The variant removes a pair of scissors' target, not a protein. Factor V Leiden is a single base change in F5 that replaces the arginine at position 506 with glutamine. Arginine 506 is one of three places activated protein C cuts activated factor V to shut clotting down. Take that site away and one of the three brakes stops working, so activated factor V lingers. The phenotype has a name of its own — activated protein C resistance — and it is measurable without touching DNA.
Which gives two tests with two failure modes. The genotype is a polymerase chain reaction looking for one letter. The functional assay is a clotting time run twice, once with added activated protein C and once without, reported as the ratio between them: a resistant plasma barely slows down when the brake is added, so its ratio is low.
The functional assay was fixed once, and knowing which version ran matters. First-generation activated protein C resistance was a plain modified aPTT and it responded to almost anything that changed clotting. Second-generation assays dilute the patient's plasma heavily into factor V-deficient plasma first, so the only factor V in the reaction is yours and the rest of the coagulation system is supplied by the reagent. That predilution is what made the test specific, and the practicalities of running and interpreting it have been set out in detail Kadauke 2014.
The site's own product for this marker is the DNA test, which sidesteps the entire interference discussion below — at the cost of only ever answering one question.
Factor V Leiden Mutation, DNA: what changes the blood, and what only changes the reading
What changes the analyte in your body: nothing. That sentence is not a shortcut. A germline single-nucleotide variant is fixed at conception and identical in every nucleated cell. No drug, diet, illness or training block alters it, and no result on this page can be improved.
What changes the functional phenotype — the activated protein C resistance ratio, in someone who does not carry the variant:
- Pregnancy, which produces acquired resistance through rising factor VIII and falling free protein S, and does it progressively across gestation.
- Estrogen exposure, including combined oral contraceptives and menopausal hormone therapy, which shift the same balance in the same direction.
- An acute-phase response, which raises factor VIII sharply and can pull a ratio down for weeks after an illness.
- Other F5 variants entirely, which produce resistance by other routes and which a targeted genotype assay reports as negative.
What changes only the reading:
- Any anticoagulant present when the blood was drawn. Heparin, vitamin K antagonists and the direct oral anticoagulants all act on the reaction the assay is timing, and the direct agents in particular distort clot-based testing in a dose- and timing-dependent way Moser 2021.
- A lupus anticoagulant, whose effect on activated protein C resistance testing has been examined specifically to ask whether it is an in vitro phenomenon or a real physiological one Shen 2011. Either way the ratio it produces is not factor V Leiden.
- Which generation of the functional assay ran. A first-generation ratio and a second-generation ratio on the same plasma are different numbers with different specificities Kadauke 2014.
- A short-filled citrate tube, which over-anticoagulates the sample before it reaches the analyzer.
- On the genotype: nothing whatsoever. There is no interference, no drug effect and no pre-analytical variable. A genotype that reads differently on a second sample means the two samples were not from the same person.
Reference interval or decision threshold — which kind of number Factor V Leiden Mutation, DNA is
The genotype has no range; it has a penetrance. Negative, heterozygous and homozygous are categories, and the number that actually informs anybody is how often carriers have events — which is a probability, not a boundary.
The functional ratio does have a cut-off, and it is a decision threshold set against the genotype. Each laboratory establishes the ratio below which it will call a sample resistant, by running samples of known genotype. It is a method-specific operating point, not a biological line Kadauke 2014.
Here is the penetrance, in the form that matters — absolute risk, and how exposure multiplies it. Across three thrombophilia strata, venous thromboembolism ran at 0.13, 0.35 and 0.94 per 100 woman-years overall. During combined oral contraceptive use the same strata ran 0.19, 0.49 and 0.86. During pregnancy they ran 0.73, 1.97 and 7.65 van Vlijmen 2011. Even in the highest stratum during pregnancy, roughly 92 women in 100 pass through a year without an event.
The relative numbers look far more dramatic than the absolute ones, which is exactly why both belong on the page. In the study that first quantified the interaction, oral contraceptive users had 3.8 times the thrombosis risk (95% CI 2.4 to 6.0), carriers of the variant 7.9 times (3.2 to 19.4), and women with both more than 30 times — 34.7, with a confidence interval running from 7.8 to 154 Vandenbroucke 1994. A confidence interval spanning a twentyfold width is telling you how few events built it.
How you would know your Factor V Leiden Mutation, DNA was wrong — and when to redraw
Never, for the genotype. This is one of two markers in the estate with a genuinely permanent answer, and a second test is only ever justified to disprove a suspected sample mix-up.
The functional assay, by contrast, has strict conditions and is worth repeating when they were not met: off heparin and off direct oral anticoagulants for at least two to three elimination half-lives Moser 2021; not during pregnancy and not within about six weeks of delivery; ideally off estrogen; and clear of an acute illness by several weeks.
How you would know a functional result was wrong:
- Order the genotype. It is the reference standard the functional cut-off was calibrated against, and it settles the question permanently Kadauke 2014.
- If the genotype is negative and the ratio is still low, the resistance is acquired — pregnancy, estrogen, factor VIII or a lupus anticoagulant Shen 2011 — and that is a different finding requiring different follow-up.
- Ask what medication was in the blood. A resistant ratio in an anticoagulated sample is an assay artifact until repeated off drug.
- Do not use D-Dimer or Fibrinogen to confirm this. Neither speaks to activated protein C resistance; they answer different questions and a normal value in either excludes nothing.
What Factor V Leiden Mutation, DNA cannot tell you
It cannot tell you that you will have a clot, and for most carriers it never happens. The absolute figures above are the honest scale of it van Vlijmen 2011. What this result changes is the conversation about specific exposures — contraception, pregnancy, long-haul travel, surgery — and that conversation belongs with a clinician who knows the family history.
It cannot be read without the exposure beside it. In one case-control series, factor V Leiden appeared in 12.2% of patients and 1.6% of controls, with an odds ratio of 5.2 (95% CI 1.4 to 19.5) that rose to 14.3 (3.3 to 64.6) among oral contraceptive users Aznar 2000. The variant and the exposure multiply; neither number means much alone.
It says nothing about arterial disease. Factor V Leiden is a venous story. Heart attack and stroke risk are addressed by ApoB, Lp(a) and blood pressure, and a negative result here provides no reassurance about any of them.
A negative genotype does not exclude activated protein C resistance. The assay looks for one letter; other F5 variants and the acquired causes above produce the phenotype without it Kadauke 2014 Shen 2011.
The wrong inference readers actually draw is that a heterozygous result is a diagnosis requiring lifelong treatment. It is a risk modifier whose absolute effect, in the absence of an exposure, is measured in fractions of a percent per year van Vlijmen 2011.
Sources read for these sections
- Kadauke S, et al. Activated protein C resistance testing for factor V Leiden. American Journal of Hematology 2014 · PMID 25293789
- Shen YM, et al. Lupus anticoagulant interference in activated protein C resistance testing: in vitro phenomenon or in vivo pathophysiologic effect?. Clinical and Applied Thrombosis/Hemostasis 2011 · PMID 21406411
- Vandenbroucke JP, et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994 · PMID 7968118
- van Vlijmen EF, et al. Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. Blood 2011 · PMID 21659542
- Aznar J, et al. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica 2000 · PMID 11114134
- Moser KA, et al. Direct oral anticoagulant (DOAC) interference in hemostasis assays. Hematology, American Society of Hematology Education Program 2021 · PMID 34889400
Factor V Leiden Mutation, DNA questions
5 answered
- What is a normal Factor V Leiden Mutation, DNA level?
- Women: Same — the estrogen interaction makes it especially relevant in women. Men: Negative / heterozygous / homozygous. Ranges vary by laboratory and assay; always compare to the range printed on your own report.
- What is the optimal Factor V Leiden Mutation, DNA level?
- Women: Negative. Men: Negative. Interpretation is categorical; see the result-category block on this page.
- What does an abnormal Factor V Leiden Mutation, DNA result mean?
- Heterozygous carriers have a modestly increased clot risk; homozygous substantially higher. Combined with estrogen contraceptives, elevated hematocrit, immobility, surgery or long flights, the risk compounds meaningfully.
- How often should I retest Factor V Leiden Mutation, DNA?
- Never — fixed for life.
- How do I test Factor V Leiden Mutation, DNA?
- Through Marek Diagnostics without a doctor's visit, drawn at a Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically through the links on this page.
Sources: Kujovich JL, Genet Med 2011 — Factor V Leiden thrombophilia review.
Turn your Factor V Leiden Mutation, DNA number into a plan
This page tells you what the number means and the order to act in. Skool is where it becomes a plan for your situation, read against your own labs.
- Supplement form, timing and how long to run it
- The hormones and compounds that move it, and what to watch
- Your retest calendar: what to draw, when, and what a change means
5.0 (15 reviews)1,500+ members

Want it built around you?
Educational and research purposes only. Not medical advice; talk to your clinician about results. Lab ranges vary by assay and laboratory: compare against the range printed on your own report. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer and affiliate disclosure